Updated: May 23, 2026

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
Published on: February 10, 2014
Xiaohong Wu1, Feng Deng, Lu Wang
1Department of Prosthodontics, The Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing 401147, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study compared how bone cells interact with Silorane-based composites versus PMMA bone cement. Using mouse parietal bones with induced defects, the researchers observed cell behavior over 38 days. At day 10, Silorane disks were covered by cells but with little attachment to the surface. By day 38, PMMA disks had better cell coverage and tissue formation. Both materials supported collagen and bone growth, but PMMA outperformed Silorane in cell adhesion. The findings suggest Silorane has potential as a bone cement alternative but requires improvement to match PMMA’s performance.
Area of Science:
Background:
Current bone cement materials face limitations in biocompatibility and integration with surrounding tissue. Traditional polymethyl methacrylate (PMMA) remains widely used despite known shortcomings in cell adhesion. Researchers have explored alternative composites to improve clinical outcomes. Silorane-based composites have emerged as a potential alternative due to their low shrinkage properties. Prior studies have shown PMMA’s effectiveness in filling bone defects but limited success in promoting tissue integration. This gap motivated the investigation of Silorane’s performance in comparison to PMMA. No prior work had resolved how Silorane-based composites interact with bone cells in vivo. Understanding these interactions could lead to better material design for orthopedic applications.
Purpose Of The Study:
The study aimed to compare the biological responses of bone cells to Silorane-based composites versus PMMA bone cement. Researchers focused on cell attachment and tissue formation around each material. The goal was to determine if Silorane could serve as a viable alternative to PMMA. The experiment used mouse parietal bone defects to simulate clinical conditions. By analyzing cell behavior over time, the team sought to assess integration potential. The comparison was necessary to evaluate Silorane’s suitability for orthopedic use. This approach allowed direct observation of material-cell interactions. The findings could inform future material development in bone repair.
The study found that PMMA supported better cell adhesion and tissue formation than Silorane-based composite.
Critical size defects were created in the parietal bones of mice to simulate clinical conditions.
Microcomputed tomography provided detailed imaging of tissue formation and cell distribution around the composite disks.
Energy-dispersive X-ray confirmed material composition and verified cell attachment to the composite surfaces.
Main Methods:
The study used mouse parietal bones with induced critical size defects. Two groups were formed: one received Silorane-based composite disks and the other PMMA disks. Cultures were maintained in vitro for 38 days to observe cell responses. Microcomputed tomography provided detailed structural analysis of the defects. Dissecting and phase-contrast microscopes captured cellular activity at different stages. Scanning electron microscopy revealed surface interactions between cells and disks. Energy-dispersive X-ray analysis confirmed material composition and cell attachment. The time points at 10 and 38 days allowed tracking of cell behavior over time.
Main Results:
At day 10, Silorane disks were covered by a cell sheet but with minimal cell attachment to the surface. PMMA disks showed extensive cell coverage and migration across the entire surface. By day 38, Silorane had some cell attachment but less than PMMA. PMMA disks were fully covered by formed tissues including collagen and bone. Both groups showed collagen fibers and globular deposits, indicating tissue formation. The Silorane composite demonstrated potential as a bone cement alternative. However, PMMA outperformed Silorane in cell adhesion and integration. These findings suggest Silorane may require modification for clinical use.
Conclusions:
The Silorane-based composite showed promise as a bone cement alternative but lagged behind PMMA in cell adhesion. Both materials supported tissue formation, but PMMA had superior integration properties. The study confirmed Silorane’s potential but highlighted its limitations in cell attachment. No prior work had resolved how Silorane interacts with bone cells in vivo. The findings suggest further refinement is necessary for Silorane to match PMMA’s performance. The authors propose that Silorane could serve as a starting point for new composite development. They suggest that improving surface properties may enhance Silorane’s biocompatibility. These conclusions align with the observed differences in cell behavior between the two materials.
Collagen fibers, globular deposits, and bone formation were observed in both Silorane and PMMA groups.
The authors propose that Silorane could serve as a starting point for new composite development with improved surface properties.